SCHEMBL30954824

SCHEMBL30954824

CCOC(=O)c1cn(-c2cnc(N3CCC3)cc2C)c2nc(N3Cc4cccnc4C3)c(Cl)cc2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 1/20 0.38
▸ SMO Q99835 4/20 0.38
▸ GRM1 Q13255 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ TP53 P04637 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ CSNK1D P48730 1/20 0.35
▸ GSK3A P49840 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ PRKCD Q05655 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ CDC42BPA Q5VT25 1/20 0.35
▸ MARK2 Q7KZI7 1/20 0.35
▸ PIM1 P11309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30298030 1.00 CSF1R (0.38) CSF1RSMOGRM1ELANELMNA
SCHEMBL30297965 0.91 GRM1 (0.38) CSF1RSMOGRM1LMNAMAPT
SCHEMBL30298068 0.89 GRM1 (0.37) SMOGRM1MAPT
SCHEMBL30298037 0.85 CSF1R (0.39) CSF1RGRM1ELANELMNAMAPT
SCHEMBL30297987 0.83 CSF1R (0.41) CSF1RSMOLMNAMAPTALDH1A1
SCHEMBL30954831 0.83 CSF1R (0.41) CSF1RSMOLMNAMAPTALDH1A1
SCHEMBL31157449 0.82 KMT2A (0.44) LMNAALDH1A1KMT2AKDM4EHTT
SCHEMBL30297993 0.81 ELANE (0.39) CSF1RELANELMNAMAPTALDH1A1
SCHEMBL31157536 0.80 EPHA2 (0.35) SMOGRM1LMNAMAPTALDH1A1
SCHEMBL31157499 0.80 GRM1 (0.42) SMOGRM1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201914-A 4-Oxo-1, 4-dihydroquinoline-3-carboxylic acid derivatives as PAPD5 and/or PAPD7 inhibitors 雷多纳治疗公司 2024-06-14 — — CN disclosed
Send feedback